Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial

IMPORTANCE: Oxaliplatin added to fluorouracil plus leucovorin therapy for patients with colon cancer has been shown to provide significant but modest absolute benefit for disease-free survival. However, acute and chronic neurotoxic effects from this regimen underscore the need for markers that predi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Song, Nan, Pogue-Geile, Katherine L., Gavin, Patrick G., Yothers, Greg, Kim, S. Rim, Johnson, Nicole L., Lipchik, Corey, Allegra, Carmen J., Petrelli, Nicholas J., O’Connell, Michael J., Wolmark, Norman, Paik, Soonmyung
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065181/
https://ncbi.nlm.nih.gov/pubmed/27270348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.2314
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados